Lusutrombopag, sold under the brand name Mulpleta among others, is a medication that has been developed for certain conditions that lead to thrombocytopenia (abnormally low platelet counts) such as thrombocytopenia associated with chronic liver disease in patients prior to elective invasive procedures.[1] It is being manufactured and marketed in Japan by Shionogi.[2][3][4] It was approved by the U.S. Food and Drug Administration ... [wikipedia]

Related Brands

Drugs with the same active ingredients